31 Leading Gene Editing Companies Shaping the Market Landscape Through 2029

Discover the top 31 companies revolutionizing genetic medicine through cutting-edge gene editing technologies. This in-depth analysis explores competitive advantages, transformative innovations, and key players poised to reshape global healthcare through precision genetic therapeutics and research applications through 2029. Access the comprehensive market research report here for further insights.

Spotlights on the Industry's Top Gene Editing Companies

The global gene editing market, valued at US$4.44 billion in 2023 and US$4.66 billion in 2024, is projected to reach US$7.59 billion by 2029 at a CAGR of 10.2%. This robust growth is driven by technological advancements in CRISPR, zinc-finger nucleases (ZFN), and TALEN systems, expanding clinical applications, rising demand for personalized medicine, and increasing prevalence of congenital and genetic disorders. These 31 industry leaders are advancing genome editing through innovative kits, reagents, libraries, software solutions, and professional services.

1. Thermo Fisher Scientific Inc.

Thermo Fisher Scientific commands a dominant position in the gene editing market through comprehensive portfolios spanning CRISPR kits, reagents, libraries, and advanced software solutions. Their Invitrogen brand delivers industry-standard gene editing tools for genome editing, knock-out, and knock-in applications. Thermo Fisher's integrated approach combining equipment, reagents, and informatics platforms enables seamless gene editing workflows across research and therapeutic development.

2. Merck KGaA

Merck KGaA delivers comprehensive gene editing solutions through its Life Science division, offering CRISPR kits, custom synthesis services, and advanced vector construction capabilities. Their expertise spans genome editing applications in drug discovery, synthetic biology, and therapeutic development. Merck's commitment to innovation and quality positions them as trusted partners for researchers and biotech companies worldwide.

3. GenScript

GenScript specializes in comprehensive gene editing services including gRNA synthesis, vector construction, and custom library development. Their integrated platform supports CRISPR, ZFN, and TALEN technologies with professional design and optimization services. GenScript's commitment to service excellence and rapid turnaround drives adoption across research institutions and therapeutic developers.

4. Agilent Technologies, Inc.

Agilent Technologies advances gene editing through innovative reagents, software solutions, and integrated platforms for genome editing applications. Their expertise in genomics, molecular biology, and life sciences research supports cutting-edge gene editing workflows. Agilent's comprehensive product portfolio enables researchers to accelerate discovery and therapeutic development.

5. Revvity, Inc.

Revvity delivers advanced solutions for gene editing research and therapeutic applications. Their portfolio includes reagents, analytical tools, and informatics platforms supporting CRISPR and alternative gene editing technologies. Revvity's focus on precision science and personalized medicine drives adoption in genomics research and drug discovery.

6. Lonza

Lonza specializes in cell and gene therapy development services, including advanced gene editing workflows and custom manufacturing. Their expertise spans CRISPR-based therapeutic development, cell engineering, and personalized medicine applications. Lonza's integrated services enable researchers and companies to accelerate from discovery to clinical translation.

7. Tecan Trading AG

Tecan delivers automated solutions and laboratory instruments supporting high-throughput gene editing workflows. Their automation platforms enable efficient CRISPR screening, knock-out, and knock-in applications at scale. Tecan's commitment to laboratory automation drives productivity and reproducibility in genomics research.

8. Sangamo Therapeutics

Sangamo Therapeutics pioneers therapeutic gene editing using zinc-finger nuclease (ZFN) technology. Their proprietary platforms enable precise genome editing for treating genetic disorders and inherited diseases. Sangamo's leadership in therapeutic gene editing drives clinical development and regulatory advancement of genetic medicines.

9. Precision Biosciences

Precision Biosciences specializes in CRISPR-based therapeutic gene editing, developing treatments for genetic blood disorders and cancers. Their proprietary ARCUS gene editing technology enables safe, precise genome modifications. Precision Biosciences' commitment to therapeutic innovation drives clinical translation of gene editing.

10. Cellectis S.A.

Cellectis advances gene editing through proprietary meganuclease technology enabling precise genome modifications. Their expertise in cell engineering and immunotherapy supports development of CAR-T cell therapies and genetic medicines. Cellectis' innovative approaches drive therapeutic applications of gene editing.

11. Regeneron Pharmaceuticals, Inc.

Regeneron leverages advanced gene editing technologies in drug discovery and therapeutic development. Their platforms support CRISPR-based screening and genetic target validation. Regeneron's integration of gene editing in their discovery pipeline drives innovation in therapeutics for diverse disease areas.

12. AmsBio

AmsBio provides comprehensive gene editing reagents, antibodies, and research tools supporting genome editing applications. Their curated portfolios enable researchers to select optimal components for CRISPR, ZFN, and TALEN-based studies. AmsBio's commitment to research quality drives adoption across academic and commercial laboratories.

13. Creative Biogene

Creative Biogene specializes in custom gene editing services including CRISPR library synthesis, vector construction, and gRNA design optimization. Their professional services support researchers in accelerating genome editing projects. Creative Biogene's expertise enables researchers to achieve complex genetic modifications efficiently.

14. Synthego

Synthego delivers rapid gRNA and gene editing reagent synthesis services with integrated informatics software. Their platform supports CRISPR screening and therapeutic development workflows. Synthego's focus on speed and quality drives adoption in high-throughput genome editing applications.

15. Takara Bio Inc.

Takara Bio provides comprehensive gene editing kits, reagents, and libraries for CRISPR and alternative technologies. Their product portfolio supports knock-out, knock-in, and genome editing applications. Takara Bio's commitment to research quality and innovation drives adoption globally.

16. Bio-Techne

Bio-Techne delivers innovative gene editing tools and antibodies supporting genome engineering research. Their comprehensive portfolio enables researchers to design and execute sophisticated gene editing experiments. Bio-Techne's focus on quality and innovation drives scientific advancement.

17. Caribou Biosciences, Inc.

Caribou Biosciences pioneers CRISPR-based cell therapy and therapeutic gene editing. Their proprietary CB system enables precise genome modifications for cell engineering and disease treatment. Caribou's commitment to therapeutic innovation drives advancement of CRISPR-based medicines.

18. Bioneer Corporation

Bioneer provides comprehensive gene editing reagents, gene synthesis services, and research tools. Their platforms support CRISPR, ZFN, and TALEN applications across research and therapeutic development. Bioneer's expertise drives adoption in genomics and molecular biology research.

19. Reprocell Inc.

Reprocell specializes in cell engineering and gene editing services for iPSC generation and cell therapy development. Their expertise supports CRISPR-based cell engineering and disease modeling. Reprocell's commitment to personalized medicine drives adoption in regenerative therapy.

20. Alstem Inc.

Alstem provides cell engineering and gene editing services for stem cell and immunotherapy applications. Their platforms support CRISPR-based cell modifications for CAR-T cell development. Alstem's expertise drives innovation in cell therapy and personalized medicine.

21. New England Biolabs

New England Biolabs delivers high-quality enzymes and reagents supporting CRISPR and alternative gene editing technologies. Their comprehensive catalog enables researchers to build custom gene editing workflows. NEB's commitment to research quality drives adoption across molecular biology applications.

22. Inscripta, Inc.

Inscripta develops automated cell programming platforms integrating CRISPR gene editing with high-throughput screening. Their Onyx platform enables efficient genome engineering at scale. Inscripta's focus on automation drives productivity in synthetic biology and strain engineering.

23. BioCAT GmbH

BioCAT provides specialized reagents and services for gene editing applications in research and therapeutic development. Their expertise spans CRISPR library design and screening. BioCAT's commitment to technical excellence supports complex genome engineering projects.

24. Integrated DNA Technologies, Inc.

Integrated DNA Technologies delivers oligonucleotide and gRNA synthesis services supporting CRISPR gene editing workflows. Their rapid synthesis capabilities and quality standards enable efficient genome editing experiments. IDT's expertise drives innovation in synthetic biology and precision medicine.

25. COBO Technologies APS

COBO Technologies specializes in CRISPR-based gene therapy and cell engineering for cancer immunotherapy. Their proprietary technology enables precise CAR-T cell engineering and immune cell modification. COBO's focus on therapeutic innovation advances next-generation cell therapies.

26. GeneCopoeia, Inc.

GeneCopoeia provides comprehensive gene editing reagents, libraries, and expression vectors supporting CRISPR applications. Their product portfolio enables researchers to execute complete genome editing workflows. GeneCopoeia's commitment to quality drives adoption in functional genomics research.

27. Hera Biolabs

Hera Biolabs specializes in advanced gene editing services and custom synthesis supporting CRISPR research and therapeutic development. Their technical expertise enables complex genome modifications. Hera Biolabs' commitment to service excellence drives adoption in preclinical research.

28. Stemcell Technologies

Stemcell Technologies delivers cell culture media, reagents, and gene editing tools supporting stem cell research and cell therapy development. Their comprehensive portfolio enables efficient cell engineering. Stemcell's focus on cell biology drives innovation in regenerative medicine.

29. Axol Bioscience Ltd.

Axol Bioscience provides human iPSC-derived cell therapies and gene editing services for disease modeling and therapeutic development. Their engineered cell lines support CRISPR-based research. Axol's expertise in cell engineering drives advancement in personalized medicine.

30. Cellecta, Inc.

Cellecta specializes in CRISPR screening libraries and cloning-free gene editing tools. Their lentiviral and pooled screening platforms enable high-throughput genome editing studies. Cellecta's focus on functional genomics drives discovery in drug development.

31. Applied Stemcell

Applied Stemcell provides gene editing services and cell engineering support for iPSC generation and therapeutic cell development. Their expertise spans CRISPR-based cell modifications and gene therapy applications. Applied Stemcell's commitment to cell engineering drives innovation in regenerative and personalized medicine.